fda glp-1 news november 2025 The has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long-term weight maintenance in certain adult patients—in just 54 days from filing Medicare's New GLP-1 Pricing Initiative

The microbiome-to-hormone signaling pathway is real

Presented for research literature review only Wang IJ et al

Insurance coverage will be a challenge if not expanded to include other conditions, one physician said, so FDA approval is paramount. This challenge echoes concerns of patients, who also list high costs as the primary obstacle to GLP-1RA treatment, according to The Cure GLP-1RA Report: Insights from Patients on GLP-1RA Medications and the Future of Obesity Treatment, which reports results of a survey of patients who had taken GLP-1RA medications

Medications like semaglutide and tirzepatide are now among the most effective tools available for sustained weight loss, and prescriptions for postpartum women have surged dramatically, rising from 0.3 to 14.6 per 1,000 deliveries between 2019 and 2024

(3) Further, research says that mold dampens glutathione levels, so if you take it in supplement form, you might boost your bodys natural defense system

4,5 Its antioxidant benefits make it a helpful option for supporting metabolic health, whether or not youre using GLP-1 medications.* 3